Related Experiment Video
Updated: May 30, 2026

Development of a Benchtop Model for Evaluating the Compatibility of Wound Dressing Materials with Negative Pressure Wound Therapy Systems
Published on: May 2, 2025
Reaching for the moon: achieving zero pressure ulcer prevalence, an update
1Methodist Medical Center of Illinios, Peoria, Illinois, USA. Isabel.bales@osfhealthcare.org
A hospital successfully eradicated hospital-acquired pressure ulcers, reducing prevalence from 9.5% to zero. This review details sustaining this success over two years post-implementation.
Area of Science:
- Healthcare Management
- Patient Safety
- Wound Care
Background:
- Hospital-acquired pressure ulcers present a significant challenge in healthcare settings.
- Previous prevalence rates indicated a substantial burden of these ulcers.
Purpose of the Study:
- To review the sustained success of a pressure ulcer eradication program.
- To highlight strategies for maintaining and improving the program over time.
Main Methods:
- Implementation of a comprehensive pressure ulcer prevention and management program.
- Ongoing monitoring and data collection on pressure ulcer prevalence.
- Program refinement based on continuous evaluation.
Main Results:
- Achieved zero prevalence of hospital-acquired pressure ulcers by December 2008.
- Sustained zero prevalence for over two years following initial eradication.
- Identified key strategies for long-term program viability.
Conclusions:
- A dedicated program can effectively eradicate hospital-acquired pressure ulcers.
- Sustained success requires ongoing commitment to program refinement and staff engagement.
- Zero pressure ulcer prevalence is an achievable goal in acute care settings.
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...